Humanigen
Humanigen FY 2021: revenue $3.6M, up 1052%; diluted EPS −$4.04
- Form
- 10-K
- Filed
- Period
- Importance
- Notable
- Accession
- 0001214659-22-003416
- Document
- 10-K
- Exhibit 10.20
- Material contract
Key figures from this report
These are the numbers Humanigen reported for the year ended Dec 31, 2021, as tagged in the filing’s XBRL data, each against the year before. A plain-English reading of this report is not written yet.
- Revenue$3.6M+1052% from $312K in FY 202010-K income statement, on EDGAR
- Net income−$236.6MAgainst −$89.5M in FY 202010-K income statement, on EDGAR
- Diluted EPS−$4.04No year-earlier figure tagged10-K income statement, on EDGAR
- Cash and cash equivalents$70.0M+3% from $67.7M in FY 202010-K balance sheet, on EDGAR
- Cash from operations−$184.0MAgainst −$69.9M in FY 202010-K cash flow statement, on EDGAR
Similar companies
Same SIC code (2834) and public float not reported.
